Accelr8 Technology Corporation (AMEX:AXK) is the 7th best-performing stock year-to-date in this segment of the market. It has risen 197.98% since the beginning of this year. Its price percentage change was 298.65% for the last 52 weeks.
"Results of the both the rapid and traditional culture showed 100% agreement with sensitivity, or resistance to clindamycin."
PDE...The 100% only deals with the AST for 10 GBS positive samples out of 32, for clindamyacin. It doesn't mean the test is capable of 100% sensitivity & specificity to detect GBS.
UNAUDITED! Look GASBAG, you're just an old nag who will never admit your possible unbridled enthusiasm might be misplaced. So be it; I have no interset in convincing you or any of other nnlx "true believers" to consider a more discerning attitude. GBS is not only tested by your "sweet baby"; CPHD has a molecular test presently on the market. The question you fail to ask is whether knowing if a patient tests positive in your 4 hour test, does the market care? Is urgency necessary for a condition that can be treated next day and still cure the patient? Just stay in your own neighborhood and we will refrain from drawing attention to your naivete. As stated before, if your board isn't "fun" enough for you; get a job!
What's wrong?!?!? Cat got yout tongue? NYCtel pee on your keyboard??!?!
Surely you have a long list of FDA approved products that detect GBS in less than 4 hours per your posts.
Restating: Detect GBS in less than 4 hours from sample taken to results verified, including antibiotic Sensitivity, with 100% Sensitivity and 100% Specivity, of course only report live bacteria!
Am ready to do more DD, so please advise if YOU KNOW OF ANY! Otherwise, will come to the conclusion that there are no other competing products that can do what NNLX - Texas Medical Center is now stating! Sure makes my investment in NNLX look even better....
Take good care;
Yes, Nanologix has 200 million shares AUTHORIZED.
Issued and Outstanding are:
"As of August 29, 2011 NanoLogix has 112,600,000 outstanding shares issued."
Humm... How's that for a FACT, with reference - link to company website.
Where do you pull your information from? Somewhere near where you sit? :-)
Rant all you want...
Attack posters all you want...
You can't change the facts about products and results!
the experts that are trying to sell you their technology because the their companies have mucho dollars invested in them. automation is great and all but you can't grow bacteria faster with all that. NNLX does what the people need. show me the sales of all those devices and how nnlx or axk for that matter have no entry into the market because one of those techs have it locked up. not too mention the nnlx version of petri dish is very new and not well known yet. technology review article written by MIT is a start into spreading the word. any way, no one really wants to argue with you. in a perfect world both techs succeed. just tell NYCTEL to stay "of" our board.
Please advise of a company with automated technology that will detect GBS in less than 4 hours, total time from sample to result, with antibiotic sensitivity, and at 100% Sensitivity and 100% Specificity.
What product(s) are currently available on the market that meets these exact specs?
You presume that stock price connotates fair and correct value. Investor emotion frequently drives price to inappropriate extremes, both too high and too low. The neurotic need that your nnlx group seems to have for comparison to AXK is a sure sign of irrational investor emotion. You posted that you are a "wealthy investor", if so, I suggest you spend some of your $$$ on unemotional due diligence. Go to ICCAC in Chicago on 9/16 and walk the floor and talk to industry experts about petri dish technology vs. automated systems.Go look at the displays of current diagnostic platforms. Not one features human hands doing streaking. There is now a Siemans platform with automated streaking so as to eliminate human error and expense.
that's not funny talking about my age :) when you turn 84 AXK may have sold their first machine...naturally they would have changed business plans and industries (well not the software part) 3 times since then. can you say GLITCH.
Lets see. 300 machines at 100k per puts them at 30 million in sales minus overhead and potential licensing if the product can prove practical....how many have they sold so far? do you really feel comfortable being invested at $3.00 a share. Did it make you feel even better when it went to the $7's just, well because it did? Rather own NNLX where I can perceive a better bang for my buck and appear much closer to FDA approval.
Tell NYCTEL to stay "of" the NNLX board.